Despite advancements in genetic testing, LS remains underdiagnosed, as current clinical criteria like the Amsterdam and Bethesda guidelines show reduced sensitivity in detecting MSH6 and PMS2 pathogenic variants. The gene discussed is PMS2; the disease is Leigh syndrome.